Cellestia at the “Transcription Factor Drug Development Virtual Congress”

Raj Lehal, CSO at Cellestia will held a presentation at the “Transcription Factor Drug Development Virtual Congress” on July 6^th, 2021.

The event focuses on developments in academic research, drug discovery and investment in targeting transcription factors of companies such as Kronos Bio, Cellestia Biotech, Novartis, BMS, Flare Therapeutics, Mayo Clinic, MIT, Foghorn.

To see the agenda of the congress click here.